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The GTPase Rab1 regulates endoplasmic reticulum-Golgi and early Golgi traffic. The guanine nucleotide exchange factor
(GEF) or factors that activate Rab1 at these stages of the secretory pathway are currently unknown. Trs130p is a subunit
of the yeast TRAPPII (transport protein particle II) complex, a multisubunit tethering complex that is a GEF for the Rab1
homologue Ypt1p. Here, we show that mammalian Trs130 (mTrs130) is a component of an analogous TRAPP complex in
mammalian cells, and we describe for the first time the role that this complex plays in membrane traffic. mTRAPPII is
enriched on COPI (Coat Protein I)-coated vesicles and buds, but not Golgi cisternae, and it specifically activates Rab1. In
addition, we find that mTRAPPII binds to 1COP, a COPI coat adaptor subunit. The depletion of mTrs130 by short
hairpin RNA leads to an increase of vesicles in the vicinity of the Golgi and the accumulation of cargo in an early Golgi
compartment. We propose that mTRAPPII is a Rab1 GEF that tethers COPI-coated vesicles to early Golgi membranes.
INTRODUCTION
In mammals, traffic between the endoplasmic reticulum (ER)
and Golgi complex requires the sequential action of two
different coat complexes, COPII (Coat Protein II) and COPI
(Aridor et al., 1995). These coat complexes are needed for
cargo selection and vesicle budding. COPII-coated vesicles
bud from a specialized region of the ER, called the transi-
tional ER (tER), and then tether and fuse with each other
(homotypic tethering/fusion) to form vesicular tubular clus-
ters (VTCs), a pre-Golgi compartment (Stephens et al., 2000;
Xu and Hay, 2004). At this compartment, another coat
complex called COPI (coat protein I) is recruited onto
membranes. Although COPII vesicles only mediate traffic
between the ER and VTCs, COPI vesicles have been im-
plicated in multiple trafficking pathways. The clearest of
these trafficking pathways are from the VTCs to the ER
and within the Golgi complex (Bonifacino and Lippincott-
Schwartz, 2003).
The GTPase Rab1 regulates both ER-Golgi and early Golgi
traffic (Plutner et al., 1991; Allan et al., 2000; Moyer et al.,
2001). In ER-Golgi traffic, activated Rab1 is required for the
recruitment of the tethering factor p115 onto COPII vesicles
(Allan et al., 2000). Tethering is a term that has been used to
describe the initial interaction of a transport vesicle with its
target membrane (Pfeffer, 1999; Whyte and Munro, 2002; Cai
et al., 2007a). Activated Rab1 also interacts with a Golgi-
associated macromolecular complex to mediate vesicle teth-
ering/fusion in early Golgi traffic. This macromolecular
complex includes the tethering factors GM130 and Giantin
(Davidson and Balch, 1993; Moyer et al., 2001; Beard et al.,
2005). Thus, Rab1 seems to regulate ER-to-Golgi (COPII
vesicle tethering) and early Golgi traffic (COPI vesicle teth-
ering) via different effectors. The guanine nucleotide ex-
change factor (GEF) that activates Rab1 is currently un-
known.
In the yeast Saccharomyces cerevisiae, several essential sub-
units of the transport protein particle (TRAPP) complexes
are required to activate the Rab1 homologue Ypt1p (Kim et
al., 2006; Cai et al., 2008); two copies of Bet3p; and one copy
each of Bet5p, Trs23p, and Trs31p (Cai et al., 2008). These
subunits are found in both the TRAPPI and TRAPPII com-
plexes. TRAPPI is required for COPII vesicle tethering (Cai
et al., 2007b), whereas TRAPPII acts after TRAPPI (Sacher et
al., 2001; Cai et al., 2005). The TRAPPI and TRAPPII com-
plexes share several subunits, whereas three additional sub-
units (Trs130p, Trs120p, and Trs65p) are unique to TRAPPII
(Sacher et al., 2001).
Previous studies have shown that mammalian Bet3
(mBet3) is recruited to the tER where it mediates homotypic
COPII vesicle tethering by binding to a subunit of the COPII
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coat cargo adaptor complex (Yu et al., 2006; Cai et al., 2007b)
that sorts cargo into COPII vesicles (Kuehn et al., 1998). This
event is required for the formation of VTCs (Yu et al., 2006).
Here, we show that mBet3 is also a component of a high-
molecular-weight TRAPP complex that is a Rab1 GEF. This
complex contains the TRAPPII-specific subunits mTrs130
and mTrs120. Mammalian TRAPPII (mTRAPPII) is enriched
on COPI-coated Golgi vesicles and buds and not Golgi cis-
ternae. In addition, we show that mTRAPPII binds to the
COPI coat adaptor subunit, 1COP. Consistent with a role
for mTRAPPII in tethering COPI-coated vesicles, the deple-
tion of mTrs130 leads to a block in anterograde traffic and
cargo accumulates in the early Golgi. We propose that
mTrs130 is a component of a mammalian Rab1 GEF that




Monoclonal antibody (mAb) directed against GM130, and anti-Sec31A anti-
body was purchased from BD Biosciences (San Jose, CA). Anti--adaptin
antibody was purchased from Sigma-Aldrich (St. Louis, MO). Monoclonal
antibodies directed against COPI (CM1A10), vesicular stomatitis virus G
(VSV-G) ectodomain, and ER–Golgi intermediate compartment (ERGIC)-53
were obtained from G. Warren (Yale University, New Haven, CT) and H.-P.
Hauri (University of Basel, Basel, Switzerland), respectively. Anti-mBet3 an-
tibody was described previously (Yu et al., 2006). Rabbit anti-mTrs130
(TRAPPC10) antibody was raised to a maltose-binding protein (MBP)
fusion protein that contained amino acids 1116-1259 (GenBank accession
NP_003265). The antibody was purified by incubating serum with a nitrocel-
lulose strip that contained the fusion protein. Anti-mTrs23 antibody was
raised to an MBP fusion of full-length mouse Trs23 (GenBank accession
NP_068561). The antibody was purified by incubating serum with a nitrocel-
lulose strip that contained the fusion protein. Rabbit anti-mTrs120 (NIK and
IKK binding protein [NIBP]) antibody was raised to an MBP fusion protein
that contained amino acids 661-994 (GenBank accession NP_083916). To pu-
rify anti-mTrs120 antibody, serum was first loaded onto an Affigel column
(Bio-Rad Laboratories, Hercules, CA) that was preloaded with MBP. The
flow-through was collected and incubated with a nitrocellulose strip that
contained the fusion protein. Bound immunoglobulin (IgG) was eluted with
0.1 M glycine, pH 2.0. Affinity-purified anti-mTrs130 and mTrs120 antibodies
did not disrupt the architecture of the Golgi or membrane traffic. Thus, these
antibodies do not inactivate mTrs130 or mTrs120 function. Polyclonal anti-
body BSTR against COPI was a kind gift of R. Pepperkok (EMBL, Heidel-
berg, Germany). Fluorescently labeled secondary antibodies were purchased
from Invitrogen.
Fluorescence Microscopy
COS-7 cells were grown on 10-mm coverslips in DMEM with high glucose
and supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA).
For the brefeldin A (BFA) (Sigma-Aldrich) experiment, BFA (5 g/ml, final
concentration) was added to the growth medium, and the sample was incu-
bated for 30 min. For the nocodazole (Sigma-Aldrich) experiments, nocoda-
zole (10 g/ml, final concentration) was added to the growth medium, and
the sample was incubated for 60 min. At the end of the incubation, the
coverslip was washed once in phosphate-buffered saline (PBS), and then
the cells were fixed and permeabilized for 15 min on ice with cold meth-
anol. The coverslip was then washed with PBS containing 0.5% bovine serum
albumin (BSA) and incubated with PBS plus 5% BSA for 60 min. The cells
were then incubated with primary antibody for 60 min, and washed three
times with PBS plus 0.5% BSA. For each wash, the sample was soaked for 5
min in buffer. The cells were then treated with secondary antibody in the
same way, and the coverslip was mounted on a slide containing Fluoremount
G (Southern Biotech, Birmingham, AL). The primary antibodies used in this
study were anti-mTrs130 (3 g/ml), anti-mTrs23 (1 g/ml), anti-GM130,
anti-ERGIC-53, anti-Sec31A, anti--adaptin, COPI and GalT. The secondary
antibodies used to localize mTrs130 were anti-rabbit IgG conjugated to Alexa
488. Anti-mouse IgG conjugated to Alexa 594 was used to localize ERGIC-53,
GM130, -adaptin, COPI, GalT, and Sec31A. Images were taken with an LSM
510 confocal microscope or an AxioVision fluorescence microscope using a
63 objective, and captured with a digital AxioCam MRm camera (Carl Zeiss
Microimaging, Thornwood, NY). For quantitation of the VSV-G trafficking
experiment described below, the area of the cell and Golgi region was defined
manually, and the mean fluorescence was measured using Photoshop (Adobe
Systems, San Jose, CA). To normalize the data, at least 27–49 cells were
analyzed from three independent experiments.
RNA Interference and VSV-G Trafficking
Vectors that target mTrs130 mRNA were constructed using short hairpin
RNA (shRNA) expression vector pSilencer 1.0-U6 (Ambion, Austin, TX). Two
mTrs130 shRNA vectors were constructed, vector1-targeted nucleotide bases
826-844 (5-GTGAAGAGCTGGAACGGAT-3), whereas vector 2 targeted
3326-3344 (5-GTGAAGAGCTGGAACGGAT-3). The pSilencer 1.0-U6 vector
(empty vector control), as well as vectors 1 and 2, was transfected twice into
COS-7 cells by using FuGENE 6 buffer (Roche Diagnostics, Indianapolis, IN).
The second transfection was done 48 h after the first transfection. The cells
were harvested 48 h after the second transfection. Samples were quanti-
tated from three independent experiments as described previously (Yu et
al., 2006).
For the complementation experiment, COS-7 cells were transfected with
pSilencer 1.0-U6 or vector 1 at 37°C. Two days later, the cells were transfected
with an expression vector that expresses green fluorescent protein (GFP) or
GFP-mTrs130* and then immunostained 48 h later. The vector (pEGFP-C3)
that expressed GFP-mTrs130* contained three silent mutations (831 G to A,
834 C to T, and 840 C to T) in the region that encodes mTrs130.
For the VSV-G-GFP trafficking experiments, four different samples were
transfected with pEGFPdKA206K-N1-VSVG tsO45 (Patterson et al., 2008)
during the second round of transfection. All samples were incubated at 37°C
for 24 h and then shifted to 42°C for 20 h. Cycloheximide was added to a final
concentration of 10 g/ml for 30 min before the cells were shifted to 32°C.
Samples were incubated at 32°C for 30, 60, and 90 min.
VSV-G transport was measured as described previously (Seemann et al.,
2000). In brief, cells were treated as described above and then fixed in 3.7%
paraformaldehyde for 15 min and stained with anti-VSV-G ectodomain anti-
body (primary antibody) and anti-mouse IgG conjugated to cyanine 5 (sec-
ondary antibody). Total VSV-G-GFP fluorescence was quantified as described
previously (Seemann et al., 2000). All images were captured at the same
setting and exposure. Cell area (A) was defined manually. The mean (I) of the
fluorescence intensity in the area was measured by Photoshop CS2. The
integrated optical density (IOD) was determined by the formula IOD  AxI.
Differences in expression level were corrected by determining the ratio of cell
surface-to-total VSV-G IOD. This was determined for thirty cells per experi-
ment, and the SEM was calculated from four independent experiments.
Electron Microscopy (EM) Analysis of mTrs130-depleted
Cells
EM was performed as described previously (Yu et al., 2006). The number of
vesicles accumulating in the Golgi area was defined as described in Seemann
et al. (2000).
The area was estimated by the point hit method (Weibel and Bolender,
1979) with an 80-nm square grid. Small vesicles were defined as circular
profiles with a diameter of 50–80 nm within the Golgi area. The results are
expressed as the number of vesicles per square micrometer of the Golgi area.
Quantification of the amount of membrane that represents Golgi cisternae
was done as described previously (Yu et al., 2006).
Preparation of NIH3T3 Cytosol and Gel Filtration
Chromatography
NIH3T3 cells were maintained in DMEM with high salt and supplemented
with 10% fetal calf serum (Invitrogen). Procedures for preparing cytosol from
NIH3T3 cells were described previously (Sacher et al., 2000). In brief, ten
15-cm plates of NIH3T3 cells at 70–80% confluence were trypsinized and
washed with PBS. Cytosol was prepared by Dounce homogenization in 1 ml
of lysis buffer (20 mM HEPES, pH 7.2). Then, NaCl, EDTA, and dithiothreitol
(DTT) were added to a final concentration of 150, 2, and 1 mM, respectively,
before protease inhibitor cocktail (as described in Waters and Blobel, 1986)
was added to 1 concentration. The lysate was centrifuged at 100,000  g for
1 h, and the supernatant was removed from the pellet. Approximately 2 mg
of cytosol was loaded onto an FPLC Superdex-200 gel filtration column (GE
Healthcare, Chalfont St. Giles, Buckinghamshire, United Kingdom), and 1-ml
fractions were collected. The fractions were concentrated by trichloroacetic
acid precipitation and resuspended in 120 l of 1 SDS sample buffer.
Samples (30 l) were analyzed by SDS-polyacrylamide gel electrophoresis
and Western blot analysis.
Immuno-EM
Cells were fixed by adding 4% freshly prepared formaldehyde in 0.1 M
phosphate buffer, pH 7.4, to an equal volume of culture medium for 10 min,
followed by postfixation in 4% formaldehyde in 0.1 M phosphate buffer, pH
7.4, without medium. Cells were stored until further processing in 1% form-
aldehyde at 4°C. Processing of cells for ultrathin cryosectioning and immu-
nolabeling according to the protein A-gold method was done as described
previously (Slot and Geuze, 2007). In brief, fixed cells were washed with 0.05
M glycine in PBS, scraped gently from the dish in PBS containing 1% gelatin,
and pelleted in 12% gelatin in PBS. The cell pellet was solidified on ice and cut
into small blocks. For cryoprotection, blocks were infiltrated overnight with
2.3 M sucrose at 4°C and then mounted on aluminum pins and frozen in
liquid nitrogen. To pick up ultrathin cryosections, a 1:1 mixture of 2.3 M
A. Yamasaki et al.
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sucrose and 1.8% methylcellulose was used (Liou et al., 1996). Affinity-
purified anti-mTrs23 (1.8 mg/ml) was diluted 1:15. COP antibody was
diluted 1:200.
Multiple grids dual-labeled for mTrs23 and COP were examined and
quantitated by electron microscopy and grouped as follows: ER, pre-Golgi,
Golgi, trans-Golgi network (TGN), and peripheral vesicles. For the TGN, a
400-nm area on the trans side of the Golgi was counted. To quantitate the
number of gold particles associated with peripheral Golgi vesicles and buds,
an area extending 200 nm on either side of the Golgi was scored.
Immunoprecipitation of the Mammalian TRAPPII
Complex
For the preparation of NIH3T3 lysate, cell pellets harvested from ten 15-cm
plates were resuspended in 2 ml of lysis buffer (20 mM HEPES, pH 7.2, and
150 mM NaCl) containing 0.1% Triton X-100. The mixture was centrifuged in
a table top centrifuge at 3000 rpm for 5 min. The supernatant was collected,
and the pellet was re-extracted in the same way. After the second extraction,
the pellet was resuspended in 2 ml of lysis buffer containing 0.5% Triton X-100
and extracted again. The supernatants were combined and centrifuged at
16,000  g for 10 min. The resulting supernatant was incubated overnight at
4°C (with agitation) with 10 g of purified anti-mTrs130 IgG, anti-mTrs120
(NIBP) IgG or nonspecific IgG, and 50 l of a slurry of protein A-Sepharose
beads. The next day, the beads were washed twice with lysis buffer containing
0.1% Triton X-100 and then two more times with lysis buffer. The beads were
analyzed by Western blot analysis or assayed for their ability to stimulate
Rab1 GEF activity. To precipitate mTRAPP from Superdex-200 column frac-
tions, fractions 9 and 10 were combined, and 10 g of purified anti-mTrs120
IgG, anti-mBet3 IgG, or nonspecific IgG was incubated overnight at 4°C with
50 l of a slurry of protein A-Sepharose beads. The next day, the beads were
washed and analyzed as described above.
Nucleotide Exchange Assays
Expression and purification of Rab1a was performed as described previously
(Machner and Isberg, 2006). For the purification of Rab4, Rab7, and Rab11,
Escherichia coli strain BL21, transformed with a plasmid (pGEX4T-1) that
contained the Rab, was grown at 37°C to an OD600 of 0.6. Protein expression
was induced during an overnight incubation at 20°C in the presence of 1 mM
isopropyl -d-thiogalactoside. The next day, cells were harvested and resus-
pended in lysis buffer (PBS, 1 mM -mercaptoethanol, 5 mM MgCl2, and
phenylmethylsulfonyl fluoride). The cells were lysed by sonication and cen-
trifuged at 10,000  g for 15 min. The cleared lysate was then loaded onto a
glutathione-Sepharose column, washed extensively with lysis buffer, and
eluted with lysis buffer containing 10 mM glutathione.
To preload Rabs with GDP, the Rabs were incubated at 30°C for 15 min in
preloading buffer (50 mM Tris pH 8.0, 100 mM KCl, 1 mM EDTA, 1 mM DTT and
1 mg/ml BSA), then fivefold excess guanosine diphosphate (GDP) was added to
the mixture. Nucleotide binding was stabilized by the addition of MgCl2 (6 mM,
final concentration) and then incubated for an additional 45 min. Free GDP
was removed by a NAP-5 desalting column. For the guanosine triphosphate
uptake assay, 10 pmol of [35S]guanosine 5-O-(3-thio)triphosphate(GTPS)
was added to 50 pmol of Rab-GDP in assay buffer (50 mM Tris, pH 7.5, 50 mM
NaCl, 1 mM DTT, and 0.1 mM EDTA). Nucleotide exchange was initiated by
transferring 8 pmol of the Rab to a tube containing the mTRAPP complex
immobilized on beads. At the indicated time points, the reaction was stopped
by the addition of ice-cold stop buffer (25 mM Tris, pH 8.0, and 20 mM
MgCl2). The reaction mixture was filtered through a nitrocellulose membrane
(Millipore, Billerica, MA) and extensively washed with stop buffer. Protein-
bound–radiolabeled nucleotide was retained on the membrane and measured
by scintillation counting.
RESULTS
One Large Mammalian TRAPP Complex Can Be Detected
by Gel Filtration Analysis
To begin to biochemically characterize mammalian TRAPP,
we raised polyclonal antibodies to all known TRAPP homo-
logues. Antibodies to five of the subunits (mTrs20, mBet3,
mTrs23, mTrs120, and mTrs130) worked by Western blot
analysis and were used in our studies. In yeast, Trs20p,
Bet3p, and Trs23p are present in the TRAPPI and TRAPPII
complexes, whereas Trs120p and Trs130p are only found in
TRAPPII (Sacher et al., 2001). When we fractionated NIH3T3
cytosol on a Superdex-200 column, we could only detect one
TRAPP complex in mammalian cells. This observation is
consistent with the results reported by two other groups
(Loh et al., 2005; Kummel et al., 2008). All TRAPP subunits
analyzed cofractionated in fractions 9 and 10 with a pre-
dicted molecular mass of 670 kDa (Figure 1A). This com-
plex is approximately the size of the yeast TRAPPII complex
(Sacher et al., 2001). Although a low-molecular-weight pool
Figure 1. A mammalian TRAPPII complex is detected in NIH3T3
cells. (A) Cytosol from NIH3T3 cells was fractionated on a Super-
dex-200 gel filtration column. The column fractions were concen-
trated as described in the Materials and Methods and mTrs130,
mTrs120, mTrs23, mBet3, and mTrs20 were detected by Western
blot analysis. (B) Fractions 9 and 10 were pooled and immunopre-
cipitated with anti-mBet3 (left, lane 2) or anti-mTrs120 IgG (right,
lane 4) to isolate the mammalian TRAPP complex. Coprecipitated
TRAPP subunits were detected by Western blot analysis. Immuno-
precipitation using nonspecific rabbit IgG was performed as a neg-
ative control (lanes 1 and 3). (C) mTrs120 interacts with mTrs130. A
10-cm plate of COS-7 cells, grown to 40% confluence, was trans-
fected with 3 g of plasmid DNA. The next day, the cells were
washed with PBS and resuspended in 1 ml of lysis buffer (20 mM
Tris, pH 7.5, 100 mM NaCl, 0.1% Triton X-100, 0.1% NP-40, and
protease inhibitor cocktail). The lysed cells were spun at 16,000  g
for 10 min at 4°C in a microfuge tube. Lysates of COS-7 cells
overexpressing GFP (SFNB 1520) and GFP-mTrs130 (SFNB 1173, left
top two panels, lanes 1 and 2), or Myc-mTrs120 (SFNB 1517, left
bottom panel, lanes 1 and 2) were processed for Western blot
analysis using anti-GFP (top two panels) or anti-Myc (bottom) an-
tibodies. The same lysates were also precipitated with anti-Myc
antibody and blotted with either anti-GFP (right, top two panels) or
anti-myc 9E10 (right, bottom) antibodies. Myc-mTrs120 only inter-
acted with GFP-mTrs130 (right top, lane 2) and not with GFP (right
middle, lane 1).
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of mBet3 was also found in fractions 15 and 16, a smaller
TRAPP complex the size of TRAPPI (300 kDa) was not
detected. A possible explanation for this observation is that
TRAPPI may be far less abundant than TRAPPII in mam-
malian cells and is not detected by the methods we use here.
When fractions 9 and 10 were pooled, precipitated with
anti-mBet3 antibody and blotted, mTrs130 and mTrs120
were present in the precipitate (Figure 1B, left). Conversely,
when these column fractions were immunoprecipitated with
an antibody directed against mTrs120, mBet3 and mTrs130
coprecipitated (Figure 1B, right). Similar results were ob-
tained with anti-mTrs130 antibody (data not shown). Two
other TRAPP subunits, mTrs23 and mTrs20, were also
shown to coprecipitate in fractions 9 and 10 (data not
shown). Therefore, based on subunit composition, these data
indicate that Superdex-200 column fractions 9 and 10 con-
tain a mammalian TRAPP complex that is analogous to yeast
TRAPPII. Here, we address the role of mTRAPPII in mem-
brane traffic.
Previously, we used two-hybrid analysis and in vitro
binding studies to identify interactions among the small
TRAPP subunits (Menon et al., 2006). This analysis did not
include TRAPPII-specific subunits. For this reason, we
wanted to address whether mTrs130 and mTrs120 directly
interact with each other; however, we were unable to
express these subunits in bacteria. To circumvent this
problem, we coexpressed Myc-tagged full-length mTrs120
(Myc-mTrs120) and GFP-tagged full-length mTrs130 (GFP-
mTrs130) in COS-7 cells (Figure 1C, left). Anti-Myc antibody
(9E10) specifically coprecipitated Myc-mTrs120 with GFP-
mTrs130, but not GFP (Figure 1C, right). We estimated that
the 9E10 antibody precipitated50% of the Myc-mTrs120 in
the lysate and 15% of the GFP-mTrs130. Although we
cannot exclude the possibility that this is an indirect inter-
action, the high efficiency of coprecipitation of mTrs130 with
mTrs120 is consistent with a direct interaction between these
two proteins.
mTRAPPII Activates Rab1
mTRAPPII contains Bet3, which plays a pivotal role in cat-
alyzing nucleotide exchange on Ypt1p (the yeast homologue
of Rab1). Three other TRAPP subunits (Trs23p, Trs31p, and
Bet5p) are also required for Ypt1p exchange activity (Kim et
al., 2006; Cai et al., 2008), and the role that each of these
subunits plays in catalyzing this activity has been described
recently (Cai et al., 2008). The high degree of conservation
among yeast and mammalian TRAPP subunits, and the
recent finding that yeast TRAPPII is a Ypt1p GEF (Cai et al.,
2008), prompted us to determine whether mTRAPPII, which
contains mTrs130 and mTrs120, is a Rab1 GEF.
To address this possibility, we precipitated the complex
from NIH3T3 lysate by using antibodies directed against the
TRAPPII-specific subunits mTrs120 and mTrs130. This en-
sured that we specifically assayed the GEF activity of TRAP-
PII and not TRAPPI. Antibody injection experiments re-
vealed that the anti-mTrs120 and mTrs130 antibodies, used
in this study, did not inactivate the function of mTrs120 or
mTrs130 (see Materials and Methods). Therefore, these anti-
bodies should not inhibit GEF activity. For our studies,
TRAPP containing protein A-Sepharose beads were washed
extensively and then assayed at 25°C for their ability to
stimulate guanine nucleotide exchange activity on Rab1. We
found that mTRAPPII stimulated the guanine nucleotide
exchange activity of Rab1 in a time-dependent manner (Fig-
ure 2A) but did not stimulate nucleotide exchange activity
on Rab11 (Figure 2B), Rab4 (Supplemental Figure S1A) or
Rab7 (Supplemental Figure S1B). The ability of mTRAPPII to
stimulate the GEF activity of Rab11 (the yeast homologue of
Ypt32p) was tested because it was recently suggested that
the addition of Trs120p and Trs130p switches yeast TRAPP
from a Ypt1p GEF to a Ypt32p GEF (Morozova et al., 2006).
We, however, have found no evidence for this proposal with
either mammalian or yeast TRAPPII (Cai et al., 2008). Ap-
proximately 0.018 pmol of mTRAPPII promoted the uptake
of 0.4 pmol of GTPS onto Rab1 in 20 min at 25°C, whereas
no stimulation of GTPS uptake was observed when the
control beads were incubated without TRAPP, or when
Rab1 was incubated with recombinant mBet3 (Figure 2A).
We estimated, from multiple time points and experiments, that
the intrinsic nucleotide exchange rate for Rab1 was 0.11 fmol/s.
This rate was 0.32 fmol/s in the presence of mTRAPPII. The
intrinsic nucleotide exchange rate for Rab11 was 0.26 fmol/s,
and no stimulation of activity was observed when mTRAPPII
was present. We conclude that the mammalian counterpart of
yeast TRAPPII is a GEF that specifically activates Rab1 but not
Rab11, Rab4, or Rab7.
Anti-mBet3 Antibody Blocks the Rab1 Guanine nucleotide
exchange activity of mTRAPPII
We described previously an antibody to mBet3 that blocks
homotypic COPII vesicle tethering in vitro and in vivo (Yu et
al., 2006). The observation that yeast Bet3p plays a pivotal
role in catalyzing nucleotide exchange on Ypt1p (Cai et al.,
2008) raised the possibility that this antibody may disrupt
membrane traffic by blocking Rab1 nucleotide exchange ac-
tivity. To address this possibility, we fractionated lysate
prepared from NIH3T3 cells on a Superdex-200 column.
This separated the free pool of mBet3 from the pool that is
part of the mTRAPPII complex (see fractions 9 and 10 in
Figure 1A). Fractions containing mTRAPPII were precipi-
tated with affinity-purified anti-mBet3 IgG, or anti-mTrs120
IgG, and blotted for the presence of mBet3. Although com-
parable amounts of mBet3 were precipitated with anti-
mBet3 IgG and anti-mTrs120 IgG (Supplemental Figure S2,
compare lanes 2 and 4), no stimulation of guanine nucleo-
tide exchange activity on Rab1 was observed when mTRAP-
PII was precipitated with anti-mBet3 IgG (Figure 2C). In
contrast, mTRAPPII still stimulated guanine nucleotide ex-
change activity on Rab1 (but not Rab11) when the complex
was precipitated with anti-mTrs120 IgG (Figure 2, C and D)
or anti-mTrs130 IgG (data not shown). Together, these find-
ings indicate that the inactivation of mBet3 blocks the
Rab1 GEF activity of mTRAPPII. They also show that
mBet3 is required but not sufficient for Rab1 exchange
activity (Cai et al., 2008), which is needed for COPII ves-
icle tethering (Bentley et al., 2006).
The TRAPPII-specific Subunit mTrs130 Largely
Colocalizes with COPI
To begin to localize the counterpart of yeast TRAPPII in
mammalian cells, we used indirect immunofluorescence mi-
croscopy to examine the localization of the TRAPPII-specific
subunit mTrs130. We found that mTrs130 resides in the
perinuclear region of COS-7 cells (Figure 3). Affinity-puri-
fied anti-mTrs130 antibody specifically recognized mTrs130,
as these perinuclear structures were not observed when
immunostaining was performed in the presence of recombi-
nant mTrs130 (Supplemental Figure S3A). Because mTrs130 is
a component of a Rab1 GEF, we colocalized mTrs130 with
Rab1 and GM130. GM130 is a Rab1 effector that colocalizes
with Rab1 on the cis side of the Golgi (Moyer et al., 2001;
Satoh et al., 2003). mTrs130 partially colocalized with Rab1
(Figure 3A), GM130 (Figure 3B), and the COPI coat complex
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(Figure 3C), which is recruited to Golgi membranes (Moelleken
et al., 2007). mTrs130 also partially colocalized with the
pre-Golgi marker ERGIC-53 (Supplemental Figure S3B), but
not Sec31A (Supplemental Figure S3C), a marker for the tER
(Barlowe et al., 1994). mTrs130 did not colocalize with the
TGN marker -adaptin (Supplemental Figure S3D), but some
mTrs130 was observed at trans-Golgi membranes marked by
GalT (Figure 3D).
To analyze the localization of mTrs130 in greater detail,
we treated COS-7 cells with nocodazole, a microtubule-
depolymerizing agent that disperses the compartments of
the ER-Golgi pathway into small punctate structures (Cole et
al., 1996). In nocodazole-treated cells, mTrs130 partially co-
localized with Rab1 (Figure 4A), GM130 (Figure 4B) and
COPI (Figure 4C), and to a lesser extent with ERGIC-53
(Supplemental Figure S4A) and GalT (Figure 4D). In addi-
tion, mTrs130 was adjacent to -adaptin (Supplemental Fig-
ure S4B), and Sec31A clustered near mTrs130 (Supplemental
Figure S4C). tER sites are known to cluster near Golgi frag-
ments in nocodazole treated cells (Hammond and Glick,
2000). Consistent with the proposal that mTrs130 extensively
colocalizes with early Golgi membranes, we found that its
localization was sensitive to BFA (Supplemental Figure S5,
bottom left). BFA is a drug that dissociates the COPI coat
from Golgi membranes (Supplemental Figure S5, bottom
right) and redistributes Golgi glycosylation enzymes to the
ER (Ward et al., 2001). Together, these findings indicate that
the mammalian homologue of the yeast TRAPPII-specific
subunit Trs130p predominantly resides on early Golgi struc-
tures and not the TGN.
mTRAPPII Is Enriched on Peripheral COPI-coated
Vesicles and Buds
If Superdex-200 column fractions 9 and 10 contain a TRAPP
complex that is analogous to yeast TRAPPII, then other
TRAPP subunits that are largely found in these fractions also
should colocalize with early Golgi markers similar to
mTrs130. We found that both anti-mTrs23 and anti-mTrs20
antibodies worked by immunofluorescence. Like mTrs130,
mTrs23 was found to be sensitive to BFA (data not shown) and
largely colocalized with GM130 and COPI in the absence (Fig-
ure 5, A and B) and presence of nocodazole (Supplemental
Figure S6, B and C). Similar results were obtained with anti-
mTrs20 antibody, although this antibody also nonspecifically
labeled the nucleus (data not shown).
Although our immunofluorescence data implies that
mTRAPPII largely resides on early Golgi membranes, these
experiments do not address whether mTRAPPII is present
on Golgi cisternae. To address this question, quantitative
immuno-EM studies were performed. Of the anti-TRAPP
antibodies used in this study, only mTrs23 worked by im-
muno-EM. Using antibodies directed against anti-mTrs23
and the COPI subunit ’COP (Figure 5C), multiple grids
were examined and profiles of Golgi areas were recorded
Figure 2. mTrs130 and mTrs120 are components of a TRAPPII complex that is a GEF for Rab1, but not Rab11. mTRAPPII was
immunoprecipitated from NIH3T3 cytosol with anti-mTrs120 IgG, and its ability to stimulate guanine nucleotide exchange activity on Rab1a
(A) or Rab11a (GeneID 8766) (B) was tested. Equal amounts of Superdex-200 column fractions 9 and 10 (Figure 1A), containing mTRAPPII,
were immunoprecipitated with anti-mBet3 IgG, nonspecific rabbit IgG, or anti-mTrs120 IgG (also see Supplemental Figure S2). An equal
volume of the protein A-Sepharose beads were then assayed 12 min for Rab1a (C) or Rab 11a (D) guanine nucleotide exchange activity.
Similar results were obtained when the complex was precipitated with anti-mTrs130 antibody (data not shown). Error bars are SEM.
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and grouped. Gold particles on ER, pre-Golgi membranes,
and the TGN were also counted. It is interesting that this
analysis revealed that Golgi-associated mTrs23 is predomi-
nantly found on the rims of Golgi cisternae and vesicular
profiles located at the Golgi periphery (Figure 5, C and D).
These rims and vesicles also contained the COPI subunit
COP (Figure 5C). Quantitation revealed that 74% of
the mTrs23-labeled gold particles were present on periph-
eral vesicles and buds in the Golgi area (Figure 5D); 71%
of the COP also localized to peripheral vesicles and
buds (Figure 5E). In addition, 1/3 of the mTrs23 positive
peripheral vesicles and buds contained COP. Together,
these findings indicate that the membrane-bound pool of
mTRAPPII is bound to COPI coated vesicles and not Golgi
cisternae.
mTRAPPII Interacts with 1COP
Studies in yeast suggested that TRAPPII-specific subunits
may play a role in tethering COPI-coated vesicles to the
Golgi. Specifically, TRAPP bound to the COPI coat complex
in yeast lysates, and COPI-coated vesicles were mislocalized
in trs120 mutants (Cai et al., 2005). Earlier studies did not
address whether TRAPPII-specific subunits bound to the
COPI coat complex, nor did they identify a subunit of the
COPI coat that interacts with TRAPPII. The localization of
mTRAPPII to COPI-coated vesicles prompted us to deter-
mine whether mTrs130 and mTrs120 interact with subunits
of the COPI coat complex. The COPI complex is composed
of two subcomplexes (Boehm and Bonifacino, 2001). The
F1-COPI subcomplex contains the , , , and  subunits,
which are homologous to the adaptins, the clathrin cargo
adaptor proteins. The B-COPI subcomplex contains the re-
maining subunits (, , and ), which may be functionally
equivalent to clathrin.
Previous studies have shown that the yeast TRAPPI com-
plex must directly interact with the COPII cargo adaptor
complex to tether COPII vesicles (Cai et al., 2007b). There-
fore, to begin to determine whether mTRAPPII interacts
with the COPI coat, we focused on the subunits of the
putative cargo adaptor complex. For this analysis, we coex-
Figure 3. mTrs130 largely colocalizes with early Golgi markers.
Colocalization experiments were performed in COS-7 cells with
antibodies directed to mTrs130 (red) and YFP-Rab1a (green) (A),
mTrs130 (green) and GM130 (red) (B), mTrs130 (green) and COPI
(red) (C), and mTrs130 (green) and the trans-Golgi marker GalT
(red) (D). The images were captured on a scanning laser confocal
microscope using a 63 objective lens. The merged images are
shown on the right, and the insets are magnified in the next row.
Bar, 20 m.
Figure 4. mTrs130 colocalizes with GM130 and COPI in nocoda-
zole treated cells. COS-7 cells were treated with 10 g/ml nocoda-
zole for 1 h before the samples were fixed and processed for staining
with antibodies directed against mTrs130 (red) and YFP-Rab1a
(green) (A), mTrs130 (green) and GM130 (red) (B), mTrs130 (green)
and COPI (red) (C), and mTrs130 (green) and GalT (red) (D). The
merged images are shown on the right, and the insets are magnified
in the next row. Bar, 20 m.
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pressed GFP-mTrs130, or Myc-mTrs120, with hemagglutinin
(HA)-tagged COPI subunits in COS-7 cells. The following
subunits were tested: , 1, 2, , and 1 and the  subunit
of B-COPI. There are two forms of COP, 1 and 2. Quan-
titative immuno-EM revealed that 1 preferentially localizes
to the cis-side of the Golgi, whereas 2 is predominantly on
the trans-side (Moellekan et al., 2007). Of all the tagged COPI
subunits that were tested (, 1, 2, , and 1 and the 
subunit of B-COPI), only 1 and COP were expressed. It is
interesting that we found that GFP-mTrs130 and Myc-
mTrs120 interacted with 1COP, but not COP (Figure 6, A
and B, lanes 2 and 3, compared with lysate in lanes 5 and 6).
This interaction seemed to be specific because mBet3,
which is known to bind to the COPII coat adaptor com-
plex (Cai et al., 2007a), does not bind to 1COP (Figure 6,
A and B, lane 1, compared with lysate in lane 4). We
estimated that 1.3% of the GFP-mTrs130 in the lysate
coprecipitated with 40% of the HA-1COP, whereas 8.2%
of the Myc-mTrs120 in the lysate coprecipitated with 37%
of the HA-1COP.
The amino terminus of 1COP, but not the carboxy ter-
minus, interacts with the dilysine motif of cargo (Harter and
Wieland, 1998; Wu et al., 2000). To determine whether this
region of 1COP specifically interacts with mTrs120 and
mTrs130, we expressed GFP-mTrs120 and GFP-mTrs130 in
COS-7 cells and compared their ability to bind to purified
recombinant GST-1COP (amino acids 1-607) and GST-
1COP (amino acids 608-874). As a control, we also ex-
pressed GFP-mBet3 in COS-7 cells and assessed its ability to
bind to both GST-1COP constructs. It is interesting that
8.4% of the GFP-mTrs120 in the binding reaction bound to
GST-1COP (1-607), but not GST or GST-1COP (608-874)
(Figure 6C, middle lanes 1–3 compared with lane 4). This
interaction seemed to be specific because no interaction was
detected with GFP-mBet3 (Figure 6C, bottom lanes 1–3
compared with lane 4). Weaker binding (2.2% of the
input lysate) also was observed with GFP-mTrs130 (Fig-
ure 6C, top lanes 1–3 compared with lane 4). Thus, the
TRAPPII-specific subunits mTrs120 and mTrs130 specifi-
cally interact with the amino terminus of 1COP, a puta-
tive cargo adaptor subunit of the COPI coat complex
(Boehm and Bonifacino, 2001). The high efficiency of the
interaction between mTrs120 and 1COP is consistent
with a direct interaction between these two proteins. Be-
cause mTrs120 and mTrs130 seem to interact with each
other, the less efficient interaction of mTrs130 with 1COP
may be either direct or through mTrs120.
mTrs130 Is Required for Golgi Architecture and Early
Golgi Traffic
To begin to address where mTrs130 functions, we trans-
fected COS-7 cells with two different shRNA expression
vectors (vector 1 and vector 2) that target mTrs130 mRNA at
different positions (see Materials and Methods). We found
that, in contrast to mock treated cells, shRNA-treated cells
were depleted of mTrs130, but not the ER protein ER60
(Figure 7A). Western blot analysis revealed that mTrs130
was reduced 76.4  8.7% with vector 1 and 51.2  11.3%
with vector 2. The loss of mTrs130 disrupted early Golgi
membranes that colocalized with COPI (data not shown)
Figure 5. The mTRAPPII complex is bound
to COPI-coated vesicles. mTrs23 (green) colo-
calizes with GM130 (red) (A) and COPI (red)
in COS-7 cells (B). (C) Immuno-EM was per-
formed in NRK cells by using anti-mTrs23
and anti-COP antibodies as described in
Materials and Methods. The arrow points to a
COPI coated bud that contains mTrs23 (15-nm
gold particles) and COP (10-nm gold parti-
cles). G denotes Golgi cisternae. Bar, 200 nm. (D
and E) Multiple grids dual-labeled for mTrs23
and ’COP were quantitated as described in
Materials and Methods. The data for mTrs23 is
shown in D and COP in E.
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and GM130 (Figure 7B). This defect was due to the loss of
mTrs130, as it was prevented by the expression of a GFP-
mTrs130 construct (GFP-mTrs130*) that harbored three si-
lent base changes (see Materials and Methods) in the sequence
targeted by the shRNA expression vector1 (Figure 7C). Sim-
ilar results were obtained with shRNA expression vector 2
(data not shown).
EM analysis confirmed that the depletion of mTrs130 dis-
rupts the architecture of the Golgi (Figure 8A, compare the
Golgi [G] in the top and bottom micrographs), and leads to
an accumulation of vesicles (50–80 nm) in the vicinity of the
Golgi complex (see filled arrows in Figure 8A, top). Quan-
titation of the data revealed a twofold increase in the num-
ber of vesicles that accumulate in the Golgi area (Figure 8B)
and a twofold decrease in the amount of membrane that
represents Golgi cisternae in the mTrs130-depleted cells
(Figure 8C).
To determine whether mTrs130 is required for Golgi traf-
fic, we transfected mock-treated and mTrs130-depleted cells
at 37°C with a plasmid that expresses tsO45 VSV-G-GFP.
Twenty-four hours after transfection, the cells were incu-
bated at 42°C to accumulate misfolded tsO45 VSV-G-GFP in
the ER. Cycloheximide was added and the cells were shifted
to 32°C for 30, 60, and 90 min. At 32°C, tsO45 VSV-G-GFP
folds into a conformation that is compatible with export
from the ER. The trafficking of VSV-G to the cell surface was
monitored at this temperature by immunofluorescence (Fig-
ure 9A) by using an antibody to the ectodomain of VSV-G as
described previously (Diao et al., 2003). The delivery of
VSV-G to the cell surface was blocked in the mTrs130-
depleted cells, but not the mock-treated cells (Figure 9). The
VSV-G that failed to be delivered to the surface in the
mTrs130-depleted cells largely colocalized with GM130 (Fig-
ure 9B, compare mock and shRNA-treated cells) and not the
TGN marker -adaptin (Supplemental Figure S7). To assess
whether the loss of mTrs130 disrupts ER-Golgi traffic, we
examined the trafficking of VSV-G at earlier times in the
mTrs130-depleted cells. By 10 min, VSV-G reached the Golgi
in both mock and depleted cells (see filled arrows in Sup-
plemental Figure S8). Approximately 30 cells were exam-
ined and no significant delay in ER–Golgi traffic was ob-
served. Additionally, no significant delay was observed in
the trafficking of the transmembrane protein ERGIC-53
(Schindler et al., 1993) from the ER to the pre-Golgi compart-
ment (data not shown). Together, these findings imply that
mTrs130 mediates early Golgi traffic and not ER–Golgi
transport.
DISCUSSION
Although a mammalian homologue of the TRAPPII-specific
subunit Trs130p was identified years ago (Sacher et al., 2000),
the role of mTrs130 and mTRAPPII in membrane traffic has
not been addressed. Here, we show that mTrs130 is a com-
ponent of a GEF that activates Rab1, but not Rab11, Rab7, or
Rab4. We also show that in the absence of mTrs130, Golgi
architecture is disrupted and anterograde early Golgi traffic
is blocked. These results are consistent with earlier studies
showing that membrane traffic between the cis- and medial-
Golgi is Rab1 dependent (Plutner et al., 1991) and that Rab1
is required for the maintenance of a functional Golgi (Wilson
et al., 1994; Haas et al., 2007).
Gel filtration analysis of an NIH3T3 lysate revealed that
mTrs130 is a component of an 670-kDa complex that in-
cludes mTrs120, and the small mTRAPP subunits mBet3,
mTrs23, and mTrs20. mTrs130, mTrs20, and mTrs23 also
Figure 6. mTRAPPII interacts with 1COP. mTrs130
(A) and mTrs120 (B) coprecipitate with HA-1COP.
The protocol used to immunoprecipitate HA-1COP
was the same as described in the legend to Figure 1C
only the cells were lysed in 50 mM Tris, pH 7.4, 100
mM NaCl, 1 mM EDTA, 1% NP-40 (plus protease
inhibitor cocktail). HA-1COP was precipitated by
incubating 1.8–2.5 mg of lysate with anti-HA–con-
jugated beads (10 l). The beads were washed three
times with 50 mM Tris, pH 7.4, 100 mM NaCl, 1 mM
EDTA, 0.5% NP-40 and processed for Western blot
analysis. The precipitate (40% of the sample) and
lysate (1% of the sample) were blotted with anti-GFP
antibody (top left), anti-myc antibody (top right) or
anti-HA antibody (bottom). GFP-mTrs130 interacted
with 1COP but not COP (Figure 6A, lanes 2 and 3,
compare to lysate in lanes 5 and 6). Myc-mTrs120
interacted with 1COP but not COP (Figure 6B,
lanes 2 and 3, compare to lysate in lanes 5 and 6). The
interaction with 1COP was specific, because mBet3
did not interact with 1COP (Figure 6, A and B, lane
1, compared with lysate in lane 4). (C) Binding as-
says were done as described in Cai et al. (2007b),
with the following modifications. Sixty microliters of
beads (2 g of fusion protein) were incubated over-
night at 4°C with 0.8 mg of lysate in a reaction
volume of 200 l. Half of the binding reaction was
loaded onto the gel.
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largely colocalize with the early Golgi markers GM130 and
COPI. Thus, all mTRAPP subunits analyzed to date, with the
exception of mBet3 (Yu et al., 2006), display the same local-
ization. Gel filtration analysis shows two pools of mBet3 in
NIH3T3 lysates, a low-molecular-weight and a high-molec-
ular-weight pool. We speculate that the low-molecular-
weight pool of mBet3, which seems to be inactive (our
unpublished observations), resides at the tER. This pool of
mBet3 may direct complex assembly at this site. Previous
studies have shown that some mBet3 also colocalizes with
early Golgi markers (Yu et al., 2006), consistent with the
observation that it is a component of the high-molecular-
weight mTRAPPII complex. These data support the hypoth-
esis that mTRAPPII is analogous to the yeast TRAPPII com-
plex. We hypothesize that the smaller TRAPPI complex is
less abundant in mammalian cells and is not detected by the
methods we have used in this study.
Our studies have shown that the loss of mTrs130 and
mBet3 lead to different phenotypes. Antibody inhibition
experiments and RNA interference studies revealed that
mBet3 is required for ER–Golgi traffic in vivo (Yu et al.,
2006). When mBet3 function is disrupted, anterograde traffic
is blocked and cargo accumulates in COPII-coated mem-
branes. In vitro, mBet3 is required for homotypic COPII
vesicle tethering and fusion (Yu et al., 2006). COPII vesicle
tethering and fusion also requires the GTPase Rab1 (Bentley et
al., 2006). Like yeast Bet3p, we show here that mBet3 is
Figure 7. The depletion of mTrs130 disrupts the early Golgi. (A)
COS-7 cells were transfected with the pSilencer 1.0-U6 vector
(mock) or vector1 (shRNA). The cells were harvested 48 h after
transfection and immunoblotted with anti-Trs130 (top) and anti-
ER60 antibodies (bottom). The ER protein ER60 was used as a
loading control. (B) COS-7 cells were transfected with pSilencer
1.0-U6 vector (mock) or vector1 (shRNA) and immunostained with
anti-mTrs130 (green) and anti-GM130 antibodies (red). (C) COS-7
cells were transfected with the pSilencer 1.0-U6 vector (mock) or
vector1 (shRNA) together with vectors that express either GFP or
GFP-mTrs130* (see Materials and Methods). The cells were immuno-
stained with anti-GM130 antibody and the number of fragmented
Golgi was quantitated in greater than 30 cells. SEM was calculated
from three independent experiments. Bar, 20 m.
Figure 8. The depletion of mTrs130 by shRNA leads to the accu-
mulation of vesicles in the vicinity of the Golgi. (A) After depleting
cells of mTrs130 by shRNA expression vector1, the cells were fixed
and processed for EM as described in the Materials and Methods. A
representative EM micrograph of mTrs130-depleted cells is shown
at the top of the figure, and the mock-treated cells are shown at the
bottom. Empty arrows point to Golgi cisternae and filled arrows to
vesicles in the vicinity of the Golgi. (B) Quantitation of the number
of vesicles per square m of Golgi area in the shRNA and mock-
treated cells. (C) Quantitation of Golgi cisternal membranes in
shRNA and mock-treated cells. p  0.0001. Bar, 1 m.
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needed but is not sufficient for Rab1 GEF activity. In
contrast to the phenotypes observed for the loss of mBet3
function, we found that the depletion of mTrs130 disrupts
Golgi traffic; as a consequence, cargo accumulates in the
early Golgi.
TRAPP interacts with the COPI coat complex in yeast
lysates, and COPI vesicles are mislocalized in trs120 mutants
(Cai et al., 2005). These findings and the observation that
TRAPPI, but not TRAPPII, binds to COPII vesicles (Sacher et
al., 2001), led to the proposal that TRAPPII-specific subunits
may mask the COPII binding site on Bet3 to convert this
Ypt1p/Rab1 GEF into a tether that specifically recognizes
COPI vesicles (Cai et al., 2008). In the present study, we
provide the first direct evidence for this proposal by dem-
onstrating that mTRAPPII localizes to COPI-coated vesicles
and buds and binds to 1COP, which is enriched on the
cis-side of the Golgi (Moelleken et al., 2007). The observation
that mTrs120 efficiently coprecipitates with 1COP fits well
with studies in yeast that showed COPI-coated vesicles are
mislocalized in trs120 mutants (Cai et al., 2005). Consistent
with a role for mTRAPPII in tethering COPI vesicles, we
show that when anterograde early Golgi traffic is blocked in
mTrs130-depleted cells, vesicles accumulate in the vicinity
of the Golgi. We propose that mTRAPPII is both a tether
and a GEF. The TRAPPII-specific subunits, mTrs130 and
mTrs120 mediate tethering functions, whereas essential
TRAPP subunits that are present in both yeast TRAPPI and
TRAPPII (Bet3, Trs23, Trs31, and Bet5) are required for Rab1
GEF activity.
It is interesting that although the yeast TRAPPII complex
is a Ypt1p (Rab1) GEF (Cai et al., 2008), it largely resides on
the late Golgi and mediates traffic throughout the Golgi,
including the late Golgi (Cai et al., 2005). This is different
from what we report here for mTrs130, which largely colo-
calizes with early Golgi markers. mTrs130 is also required
for early Golgi traffic and does not seem to be needed for
membrane traffic at the TGN. Although the components of
the secretory apparatus are highly conserved, differences in
the architecture of the ER–Golgi pathway between yeast and
mammals could explain why TRAPPII seems to localize and
function in different compartments in lower and higher eu-
karyotes. Our findings imply that the GTPase Ypt1p regu-
lates the flow of traffic into the cis - and trans-sides of the
yeast Golgi, whereas Rab1 regulates traffic into the cis-face of
the Golgi. In mammals, a related Rab family member may
regulate traffic into the trans-Golgi.
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